FDA Adverse Event Injury Summary report: N

PRODISC-C IMPLANT MEDIUM DEEP 5MM-STERILE

MDR report key: 2800437 · Received October 17, 2012

Report

Report Number
2530088-2012-00940
Event Type
Injury
Date Received
October 17, 2012
Date of Event
September 18, 2012
Report Date
September 18, 2012
Manufacturer
SYNTHES BRANDYWINE
Product Code
MJO
PMA / PMN Number
P070001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

IT IS UNCLEAR WHAT HAPPENED IN THIS CASE WITH THE PROVIDED INFO. IT IS NOT CLEAR WHETHER THE IMPLANT WAS PLACED FAR ENOUGH POSTERIORLY AT THE TIME OF IMPLANTATION OR IF IT MOVED IN-VIVO. THIS IMPLANT HAS BEEN SHOWN TO WITHSTAND NORMAL PHYSIOLOGIC LOADING IN THE CERVICAL SPINE AND THE PROPER INSERTION TECHNIQUE IS EXTENSIVELY COVERED IN THE TECHNIQUE GUIDE AS WELL AS IN MANDATORY SURGEON TRAINING. THE DESIGN RISK ASSESSMENT WAS REVIEWED AND WAS FOUND TO BE ADEQUATE FOR THE INTENDED USE. A DEVICE HISTORY RECORDS REVIEW HAS BEEN REQUESTED.

Additional Manufacturer Narrative · 1

DEVICE USED AS TREATMENT. THE RAW MATERIAL AND DEVICE HISTORY RECORDS WERE REVIEWED AND NO NONCONFORMITIES WERE FOUND. THE REVIEW OF THE RECORDS SHOWS THAT THE PARTS WERE PROCESSED WITHIN SPECIFICATION.

Additional Manufacturer Narrative · 1

DEVICE USED FOR TREATMENT AND NOT DIAGNOSIS. INFORMATION FROM RECEIVED QUESTIONNAIRE.

Description of Event or Problem · 1

IT WAS NOTED THAT THE IMPLANT WAS INTACT UPON REMOVAL.

Description of Event or Problem · 1

IT WAS REPORTED TO SYNTHES: SURGEON PERFORMED A PRODISC-C REMOVAL IT WAS REPORTED THAT THE PRODISC-C IMPLANT WAS REMOVED FROM LEVEL C5-6 BECAUSE IT WAS COMING OUT OF THE VERTEBRAL BODIES. SUBSEQUENTLY, THE SURGEON PERFORMED A FUSION ON THE PT FOLLOWING THE IMPLANT REMOVAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PRODISC-C IMPLANT MEDIUM DEEP 5MM-STERILE PRODISC-C IMPLANT MJO SYNTHES BRANDYWINE 6784157

Patients

Seq Age Sex Outcome Treatment
1 36 YR Required Intervention